147 related articles for article (PubMed ID: 29740032)
1. Patient-derived mutations within the N-terminal domains of p85α impact PTEN or Rab5 binding and regulation.
Mellor P; Marshall JDS; Ruan X; Whitecross DE; Ross RL; Knowles MA; Moore SA; Anderson DH
Sci Rep; 2018 May; 8(1):7108. PubMed ID: 29740032
[TBL] [Abstract][Full Text] [Related]
2. The p85alpha subunit of phosphatidylinositol 3'-kinase binds to and stimulates the GTPase activity of Rab proteins.
Chamberlain MD; Berry TR; Pastor MC; Anderson DH
J Biol Chem; 2004 Nov; 279(47):48607-14. PubMed ID: 15377662
[TBL] [Abstract][Full Text] [Related]
3. Impact of p85α Alterations in Cancer.
Marshall JDS; Whitecross DE; Mellor P; Anderson DH
Biomolecules; 2019 Jan; 9(1):. PubMed ID: 30650664
[TBL] [Abstract][Full Text] [Related]
4. Identification of mutations in distinct regions of p85 alpha in urothelial cancer.
Ross RL; Burns JE; Taylor CF; Mellor P; Anderson DH; Knowles MA
PLoS One; 2013; 8(12):e84411. PubMed ID: 24367658
[TBL] [Abstract][Full Text] [Related]
5. Direct positive regulation of PTEN by the p85 subunit of phosphatidylinositol 3-kinase.
Chagpar RB; Links PH; Pastor MC; Furber LA; Hawrysh AD; Chamberlain MD; Anderson DH
Proc Natl Acad Sci U S A; 2010 Mar; 107(12):5471-6. PubMed ID: 20212113
[TBL] [Abstract][Full Text] [Related]
6. Multiple roles for the p85α isoform in the regulation and function of PI3K signalling and receptor trafficking.
Mellor P; Furber LA; Nyarko JN; Anderson DH
Biochem J; 2012 Jan; 441(1):23-37. PubMed ID: 22168437
[TBL] [Abstract][Full Text] [Related]
7. Regulation of the PI3K pathway through a p85α monomer-homodimer equilibrium.
Cheung LW; Walkiewicz KW; Besong TM; Guo H; Hawke DH; Arold ST; Mills GB
Elife; 2015 Jul; 4():e06866. PubMed ID: 26222500
[TBL] [Abstract][Full Text] [Related]
8. Insight into the PTEN - p85α interaction and lipid binding properties of the p85α BH domain.
Marshall JDS; Mellor P; Ruan X; Whitecross DE; Moore SA; Anderson DH
Oncotarget; 2018 Dec; 9(97):36975-36992. PubMed ID: 30651929
[TBL] [Abstract][Full Text] [Related]
9. Deregulation of Rab5 and Rab4 proteins in p85R274A-expressing cells alters PDGFR trafficking.
Chamberlain MD; Oberg JC; Furber LA; Poland SF; Hawrysh AD; Knafelc SM; McBride HM; Anderson DH
Cell Signal; 2010 Oct; 22(10):1562-75. PubMed ID: 20570729
[TBL] [Abstract][Full Text] [Related]
10. Caspase 8 promotes peripheral localization and activation of Rab5.
Torres VA; Mielgo A; Barilà D; Anderson DH; Stupack D
J Biol Chem; 2008 Dec; 283(52):36280-9. PubMed ID: 18974049
[TBL] [Abstract][Full Text] [Related]
11. Identification of the Rab5 binding site in p110β: assays for PI3Kβ binding to Rab5.
Salamon RS; Dbouk HA; Collado D; Lopiccolo J; Bresnick AR; Backer JM
Methods Mol Biol; 2015; 1298():271-81. PubMed ID: 25800850
[TBL] [Abstract][Full Text] [Related]
12. Oncogenic mutations weaken the interactions that stabilize the p110α-p85α heterodimer in phosphatidylinositol 3-kinase α.
Echeverria I; Liu Y; Gabelli SB; Amzel LM
FEBS J; 2015 Sep; 282(18):3528-42. PubMed ID: 26122737
[TBL] [Abstract][Full Text] [Related]
13. A single discrete Rab5-binding site in phosphoinositide 3-kinase β is required for tumor cell invasion.
Heitz SD; Hamelin DJ; Hoffmann RM; Greenberg N; Salloum G; Erami Z; Khalil BD; Shymanets A; Steidle EA; Gong GQ; Nürnberg B; Burke JE; Flanagan JU; Bresnick AR; Backer JM
J Biol Chem; 2019 Mar; 294(12):4621-4633. PubMed ID: 30659094
[TBL] [Abstract][Full Text] [Related]
14. Rab5 and Ndfip1 are involved in Pten ubiquitination and nuclear trafficking.
Li Y; Low LH; Putz U; Goh CP; Tan SS; Howitt J
Traffic; 2014 Jul; 15(7):749-61. PubMed ID: 24798731
[TBL] [Abstract][Full Text] [Related]
15. Targeting therapeutic liabilities engendered by PIK3R1 mutations for cancer treatment.
Cheung LW; Mills GB
Pharmacogenomics; 2016 Feb; 17(3):297-307. PubMed ID: 26807692
[TBL] [Abstract][Full Text] [Related]
16. Association of phosphatidylinositol 3-kinase composed of p110beta-catalytic and p85-regulatory subunits with the small GTPase Rab5.
Kurosu H; Katada T
J Biochem; 2001 Jul; 130(1):73-8. PubMed ID: 11432782
[TBL] [Abstract][Full Text] [Related]
17. Phosphoinositide 3-kinase regulatory subunit p85alpha suppresses insulin action via positive regulation of PTEN.
Taniguchi CM; Tran TT; Kondo T; Luo J; Ueki K; Cantley LC; Kahn CR
Proc Natl Acad Sci U S A; 2006 Aug; 103(32):12093-7. PubMed ID: 16880400
[TBL] [Abstract][Full Text] [Related]
18. Structural basis of Rab5-Rabaptin5 interaction in endocytosis.
Zhu G; Zhai P; Liu J; Terzyan S; Li G; Zhang XC
Nat Struct Mol Biol; 2004 Oct; 11(10):975-83. PubMed ID: 15378032
[TBL] [Abstract][Full Text] [Related]
19. Phosphate-binding loop and Rab GTPase function: mutations at Ser29 and Ala30 of Rab5 lead to loss-of-function as well as gain-of-function phenotype.
Li G; Liang Z
Biochem J; 2001 May; 355(Pt 3):681-9. PubMed ID: 11311130
[TBL] [Abstract][Full Text] [Related]
20. Disrupted RabGAP function of the p85 subunit of phosphatidylinositol 3-kinase results in cell transformation.
Chamberlain MD; Chan T; Oberg JC; Hawrysh AD; James KM; Saxena A; Xiang J; Anderson DH
J Biol Chem; 2008 Jun; 283(23):15861-8. PubMed ID: 18387942
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
